Ruxolitinib significantly reduces disease and improves quality of life in patients

The treatment strategy for primary myelofibrosis (PMF) is based on risk stratification. Due to the variety of clinical manifestations and issues to be addressed in PMF patients, treatment strategies need to take into account the patient's disease and clinical needs. Initial treatment with ruxoli

Heart disease needs a new drug – Vericiguat

Heart failure with reduced ejection fraction (HFrEF) is a major type of heart failure, and the China HF Study showed that 42% of heart failures in China are HFrEF, although several standard therapeutic classes of drugs are available for HFrEF and have reduced the risk of death and hospitalization fo

Targeted drug for the treatment of myelofibrosis: Ruxolitinib

Myelofibrosis (MF) is referred to as myelofibrosis. It is also a very rare disease. And the cause of its pathogenesis is not known. Typical clinical manifestations are juvenile red blood cell and juvenile granulocytic anemia with a high number of tear drop red blood cells. Bone marrow aspiration oft

You should know at least these 3 points about rivaroxaban

As a new oral anticoagulant, rivaroxaban has been widely used in the prevention and treatment of venous thromboembolic disease and stroke prevention in non-valvular atrial fibrillation. In order to use rivaroxaban more reasonably, you should know at least these 3 points.I. The difference between riv

Changzhou Pharmaceutical received approval to produce Lenalidomide Capsules

Changzhou Pharmaceutical Factory Ltd.,a subsidiary of Shanghai Pharmaceutical Holdings, received the Drug Registration Certificate (Certificate No. 2021S01077, 2021S01078, 2021S01079) issued by the State Drug Administration forLenalidomide Capsules(Specification 5mg, 10mg, 25mg), w

What are the precautions for rivaroxaban tablets?

Rivaroxaban, as a new oral anticoagulant, has been widely used in the prevention and treatment of venous thromboembolic diseases. What do I need to pay attention to when taking rivaroxaban?Unlike warfarin, rivaroxaban does not require monitoring of blood clotting indicators. Changes in renal functio